Cargando…

Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease

This review summarizes the published literature referring to the use and validity of the biomarker soluble urokinase plasminogen activator receptor (suPAR) when used for the assessment of patients with cardiac diseases. It is measured by enzyme-linked immunosorbent assay (ELISA) in plasma samples. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velissaris, Dimitrios, Zareifopoulos, Nicholas, Koniari, Ioanna, Karamouzos, Vasilios, Bousis, Dimitris, Gerakaris, Andreas, Platanaki, Christina, Kounis, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016523/ https://www.ncbi.nlm.nih.gov/pubmed/33854652 http://dx.doi.org/10.14740/jocmr4459

Ejemplares similares

Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
por: Velissaris, Dimitrios, et al.
Publicado: (2022)

Presepsin as a Diagnostic and Prognostic Biomarker in Sepsis
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Evaluation of Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Patients With COVID-19 and Non-COVID-19 Pneumonia: An Observational Cohort Study
por: Velissaris, Dimitrios, et al.
Publicado: (2021)

Correlation of Positive Blood Cultures with Peripherally Inserted Central Catheter Line Infection in Oncology Patients
por: Platanaki, Christina, et al.
Publicado: (2021)

Effect of atrial fibrillation on cognitive function in heart failure patients
por: Ktenopoulos, Nikolaos, et al.
Publicado: (2021)

Digoxin Impact on Heart Failure Patients with Atrial Fibrillation
por: Gerakaris, Andreas, et al.
Publicado: (2022)

The Use of Electroencephalography in Patients with Sepsis: a Review of The Literature
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2021)

Use of Sodium Bicarbonate in Cardiac Arrest: Current Guidelines and Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2016)

Atrial fibrillation in patients with systolic heart failure: pathophysiology mechanisms and management
por: Koniari, Ioanna, et al.
Publicado: (2021)

A Literature Review of Pathophysiology, Clinical Manifestations, Medications and Optimal Dosage, Outpatient, and Post-hospitalization Use of Anticoagulation in COVID-19 Patients
por: Velissaris, Dimitrios, et al.
Publicado: (2023)

The euphoria, the warnings and the downfall of the current bioresorbale stents: could the journey be restarted?
por: Kounis, Nicholas G., et al.
Publicado: (2018)

Kounis Syndrome—not a Single-organ Arterial Disorder but a Multisystem and Multidisciplinary Disease
por: Kounis, Nicholas G., et al.
Publicado: (2019)

The pathogenesis of potential myocarditis induced by COVID-19 vaccine
por: Kounis, Nicholas G., et al.
Publicado: (2022)

C-Reactive Protein and Frailty in the Elderly: A Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2017)

Prognostic Role of Soluble Urokinase Plasminogen Activator Receptor at the Emergency Department: A Position Paper by the Hellenic Sepsis Study Group
por: Velissaris, Dimitrios, et al.
Publicado: (2020)

Hypersensitivity to metallic implants: pathophysiologic and diagnostic considerations
por: Nicholas G., Kounis, et al.
Publicado: (2018)

Impact of Bacterial Infections on COVID-19 Patients: Is Timing Important?
por: Michailides, Christos, et al.
Publicado: (2023)

Outcomes of Atrioventricular Node Ablation and Pacing in Patients with Heart Failure and Atrial Fibrillation: From Cardiac Resynchronization Therapy to His Bundle Pacing
por: Koniari, Ioanna, et al.
Publicado: (2023)

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
por: Erkut, Nergiz, et al.
Publicado: (2016)

Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients
por: Wlazeł, Rafał Nikodem, et al.
Publicado: (2018)

Restrictive perimembranous ventricular septal defect with left to right Shunt post urgent aortic balloon valvuloplasty and transcatheter aortic valve replacement
por: Chourdakis, Emmanouil, et al.
Publicado: (2018)

Anaphylaxis-Induced Atrial Fibrillation and Anesthesia: Pathophysiologic and Therapeutic Considerations
por: Kounis, Nicholas G, et al.
Publicado: (2020)

The conundrum of thrombosis with thrombocytopenia syndrome following COVID-19 vaccines
por: Kounis, Nicholas G., et al.
Publicado: (2022)

Incidence, pathophysiology, predictive factors and prognostic implications of new onset atrial fibrillation following transcatheter aortic valve implantation
por: Koniari, Ioanna, et al.
Publicado: (2018)

Hypersensitivity coronary myocardial infarction (Kounis syndrome) and COVID-19 vaccines
por: Kounis, Nicholas G., et al.
Publicado: (2022)

Rare Hypersensitivity Myocardial Reactions Following COVID-19 Vaccination: Hypersensitivity Myocardial Infarction (Kounis Syndrome) and Hypersensitivity Myocarditis
por: Kounis, Nicholas G., et al.
Publicado: (2022)

Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin's Lymphoma
por: Kouhpayeh, Shirin, et al.
Publicado: (2017)

Cardiac arrest caused by nafamostat mesilate: Kounis syndrome in the dialysis room?
por: Koniari, Ioanna, et al.
Publicado: (2017)

The Use of Pulmonary Artery Catheter in Sepsis Patients: A Literature Review
por: Velissaris, Dimitrios, et al.
Publicado: (2016)

Biomarkers in the clinical management of patients with atrial fibrillation and heart failure
por: Koniari, Ioanna, et al.
Publicado: (2021)

The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update
por: Pantzaris, Nikolaos-Dimitrios, et al.
Publicado: (2018)

Soluble Urokinase Plasminogen Activator Receptor as a Marker for Use of Antidepressants
por: Haastrup, Eva, et al.
Publicado: (2014)

Soluble urokinase plasminogen activator receptor predicts mortality in exacerbated COPD
por: Godtfredsen, Nina S., et al.
Publicado: (2018)

Soluble urokinase plasminogen activator receptor for the prediction of ventilator-associated pneumonia
por: van Oort, Pouline M., et al.
Publicado: (2019)

Kinetics of the soluble urokinase plasminogen activator receptor (suPAR) in cirrhosis
por: Garnæs, Emilie, et al.
Publicado: (2019)

Soluble urokinase plasminogen activator receptor level in individuals of advanced age
por: Wlazel, Rafal N., et al.
Publicado: (2020)

Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID‐19
por: Luo, Shengyuan, et al.
Publicado: (2022)

Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives
por: Chourdakis, Emmanouil, et al.
Publicado: (2021)

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2012)

Diagnostic and Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis and Impact of Detection Method
por: Winnicki, Wolfgang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_sbnn7po67s45ralp1db4f1ubpe